All About Vimpat—An Epilepsy Add-on Treatment

I have 0 questions View All

An Add-On Epilepsy Treatment For Partial-Onset Seizures in Adults with Epilepsy

Have you ever said “I'm okay” when asked how you were doing, even when you knew you really weren't? You are not alone. Despite your efforts to get there, you may not have reached your personal best level of seizure control just yet. But there is hope. Vimpat may help you gain additional partial-onset seizure control.

The first step toward gaining additional seizure control is to ask for it. Start learning about Vimpat and how it may help you.

What is Vimpat?

Vimpat is an add-on medication that is used to treat partial-onset seizures in adults.

Studies suggest that Vimpat works well when added to other epilepsy medicines. Adding Vimpat to your current anti-seizure medication may provide better partial-onset seizure control. Vimpat has been proven to significantly reduce the number of partial-onset seizures when added to the most common anti-seizure medications, including Keppra®*, Topamax®, Lamictal®, Trileptal®, Depakote®, Phenobarbital, Dilantin®, Tegretol®, and Zonegran®. In clinical studies, more patients who added Vimpat reduced their partial-onset seizures by 50% or more compared to those who added placebo.

In clinical trials, the most common side effects seen with Vimpat were dizziness, headache, nausea, and double vision. Additionally, it is important to note that antiepileptic drugs, including VIMPAT, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your healthcare provider right away if you have new or worsening symptoms of depression, any unusual changes in mood or behavior, or suicidal thoughts, behavior, or thoughts about self harm that you have never had before or may be worse than before. See additional important safety information below.

When will you decide that just okay just isn’t? You have the right to ask your neurologist if VIMPAT is right for you.

Who is Vimpat for?

When someone might have asked you how you were doing, did you just happen to say, “I’m okay,” even when you knew you really weren’t? You are not alone. Despite your efforts to get there, you may not have reached your personal best level of seizure control just yet. But there is hope.

Ask your neurologist if VIMPAT is right for you.

What else should I know about Vimpat?

Indication

Vimpat® (lacosamide) is a prescription medicine that is used with other medicines to treat partial-onset seizures in people 17 years of age and older with epilepsy.

Important Safety Information

Vimpat may not be for everyone. Ask your healthcare provider if Vimpat is right for you.

Warnings and Precautions

Antiepileptic drugs, including Vimpat, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your healthcare provider right away if you have new or worsening symptoms of depression, any unusual changes in mood or behavior, or suicidal thoughts, behavior, or thoughts about self harm that you have never had before or may be worse than before.

Do not stop taking VIMPAT without first talking to your healthcare provider. Stopping Vimpat suddenly can cause serious problems. Stopping seizure medicine suddenly in a patient who has epilepsy can cause seizures that will not stop.

Vimpat may also cause you to feel dizzy, have double vision, feel sleepy, or have problems with coordination and walking. You should not drive, operate machinery or do other dangerous activities until you know how Vimpat affects you.

Vimpat may cause you to have an irregular heartbeat or may cause you to feel faint. Call your healthcare provider if you have a fast, slow, or pounding heartbeat, shortness of breath, feel lightheaded, or if you fainted or feel like you are going to faint.

Vimpat is a federally controlled substance (C-V) because it can be abused or lead to drug dependence. Keep your Vimpat in a safe place to protect it from theft. Do not give it to anyone else, because it may harm them.

In rare cases, Vimpat may cause a serious allergic reaction that may affect your skin or other parts of your body such as your liver or blood cells. Call your healthcare provider right away if you have a skin rash or hives, fever or swollen glands that do not go away, shortness of breath, swelling of the legs, yellowing of the skin or whites of the eyes, or dark urine.

Before taking Vimpat, tell your healthcare provider if you have or have had depression, mood problems, or suicidal thoughts or behavior; have heart, kidney or liver problems; have abused prescription medicines, street drugs or alcohol in the past, are pregnant or plan to become pregnant.

Vimpat® oral solution contains aspartame, a source of phenylalanine.

Common Adverse Reactions

In clinical trials, the most common side effects seen with Vimpat were dizziness, headache, nausea, and double vision.

Talk to your healthcare provider about other possible side effects with VIMPAT. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see additional patient information in the Patient Medication Guide. This information does not take the place of talking with your healthcare provider about your condition or your treatment.


*KEPPRA (LEVETIRACETAM)

INDICATION

KEPPRA is a prescription medicine taken by mouth that is used with other medicines to treat partial-onset seizures in people 1 month of age and older with epilepsy.

UCB is the manufacturer of Keppra.

IMPORTANT SAFETY INFORMATION

Warnings and Precautions

Antiepileptic drugs, including KEPPRA, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your healthcare provider right away if you have new or worsening symptoms of depression, any unusual changes in mood or behavior, or suicidal thoughts, behavior, or thoughts about self harm that you have never had before or may be worse than before.

Common Adverse Reactions

The most common side effects seen in people who took KEPPRA in clinical studies were sleepiness, weakness, infection, and dizziness. In clinical trials of KEPPRA in children, the most common side effects in addition to those listed for adults were tiredness, acting aggressive, nasal congestion, decreased appetite, and irritability.

Please see www.keppraxr.com for additional safety information including the Patient Medication Guide.

Veronica - views on treatment and not selling

Important Safety Information Read the Transcript

Display transcript content....